Join the 'Naloxone' group to help and get support from people like you.
Naloxone News
Biden Administration Calls for Greater Access to Overdose Antidote
WEDNESDAY, March 13, 2024 – The White House on Wednesday launched a nationwide call for more training and better access to the lifesaving opioid overdose drug naloxone. Called the Challenge to Save...
FDA Announces Shelf-Life Extension for Narcan (naloxone) Nasal Spray
January 17, 2024 – Today, FDA is announcing that Emergent BioSolutions is extending the shelf-life of newly manufactured NARCAN (naloxone hydrochloride) 4 milligram (mg) Nasal Spray products from...
Biden Administration Urges Schools to Carry Naloxone
TUESDAY, Oct. 31, 2023 – The Biden administration is encouraging schools throughout the United States to carry naloxone (Narcan) to help prevent fatal drug overdoses in students. The medication was...
Biden Administration Urges Schools to Carry Naloxone, the Opioid Overdose Treatment
TUESDAY, Oct. 31, 2023 – The Biden administration is encouraging schools throughout the United States to carry naloxone to help prevent fatal drug overdoses in students. The medication (Narcan) was...
Two-Thirds of Americans Say Their Lives Have Been Affected by Addiction: Poll
TUESDAY, Aug. 15, 2023 – Millions of Americans are addicted to drugs or alcohol, and millions more struggle with an addicted family member or friend, a new poll finds. Two-thirds of those surveyed...
Just 1 in 5 Americans Struggling With Opioid Misuse Gets Meds That Can Help
MONDAY, Aug. 7, 2023 – The U.S. opioid abuse epidemic wages on, and overdose deaths continue to rise, yet just 1 in 5 people receives potentially lifesaving medication such as methadone,...
FDA Approves Second OTC Naloxone Spray, ReVive, for Suspected Opioid Overdose
THURSDAY, Aug. 3, 2023 – The U.S. Food and Drug Administration has approved RiVive, an over-the-counter (OTC) naloxone hydrochloride nasal spray for emergency treatment of known or suspected opioid...
Monthly News Roundup - July 2023
FDA Clears Opill, the First Over-the-Counter (OTC) Oral Birth Control Pill History in women’s health was made in July when the FDA cleared Opill (norgestrel 0.075 mg), the first over-the-counter (...
FDA Approves RiVive (naloxone hydrochloride) Over-the-Counter Nasal Spray for the Emergency Treatment of Opioid Overdose
Pittsburgh, Pennsylvania--(Newsfile Corp. - July 28, 2023) - Harm Reduction Therapeutics (HRT), Inc., a nonprofit pharmaceutical company, announced today that FDA has approved OTC RiVive™ (naloxone H...
Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
FRIDAY, April 21, 2023 – The company that makes the opioid overdose nasal spray Narcan plans to have it available in pharmacies and online by late summer for a price of less than $50. Emergent sent...
Maker of Narcan Nasal Spray Plans to Sell Overdose Antidote for Less Than $50
FRIDAY, April 21, 2023 – The company that makes the opioid overdose nasal spray Narcan plans to have it available in pharmacies and online by late summer for a price of less than $50. Emergent sent...
2012 to 2019 Saw Rise in Naloxone Rx in the Emergency Department
MONDAY, April 17, 2023 – Rates of prescriptions for naloxone in emergency departments increased from 2012 to 2019, according to a study published in the March issue of the American Journal of...
Monthly News Roundup - March 2023
FDA Approves First Over-the-Counter (OTC) Naloxone Nasal Spray for Opioid Overdoses In late March, the FDA approved an Rx-to-OTC switch for Narcan (naloxone 4 mg) nasal spray for over-the-counter...
FDA Approves First Over-the-Counter Nasal Spray for Opioid Overdoses
WEDNESDAY, March 29, 2023 – The U.S. Food and Drug Administration on Wednesday approved the over-the-counter (OTC) use of naloxone (Narcan). "Today's approval of OTC naloxone nasal spray will help...
FDA Approves Over-the-Counter Designation for Emergent BioSolutions’ Narcan Nasal Spray, a Historic Milestone for the Opioid Overdose Emergency Treatment
GAITHERSBURG, Md., March 29, 2023 (GLOBE NEWSWIRE) – Today, Emergent BioSolutions Inc. (NYSE: EBS) announced that the U.S. Food and Drug Administration (FDA) has approved Narcan® Naloxone HCl Nasal ...
Ask a question
To post your own question to this support group, sign in or create an account.